Find someone diagnosed with cancer, and they will have likely been treated with radiation therapy, chemotherapy, or by having the tumor surgically removed. Treatment is hardly enjoyable, but it is usually quite effective. With so many success stories from survivors, it may be tempting to ask why continuing to fund…...
Supporting the Women’s Venture Competition
The National Foundation for Cancer Research is honored to be an official partner for a highly unique investment event designed specifically to highlight, energize and fund promising cancer treatment technology companies led by female scientist-entrepreneurs. The AIM-HI Accelerator Fund’s Women’s Venture Competition, which will be held on May 20 at…...
NFCR Funded Translational Cancer Research Project Receives Virginia Catalyst Grant
FOR IMMEDIATE RELEASE: December 23, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance…...
Giving Tuesday: The Global Day of Giving
The holiday season has many people thinking about giving gifts and embracing the spirit of generosity. Most of the beautiful generosity is close to home, spoiling loved ones with presents and treats. Giving Tuesday was established in 2012 as a way to harness the generosity of the season and encourage…...
Charitable Giving and Tax Benefits
The 2018 tax changes introduced some confusion with respect to the tax advantages of charitable donations. With the caps on State and Local tax deductions coupled with a virtual doubling of the standard deductions, many folks who have previously itemized deductions are now taking the higher standard deduction. What does…...
Disruptive Funding Model to Advance Innovations—A New Approach to Ending Cancer for Each and for All
The National Foundation for Cancer Research funds “high risk|high reward” research with a singular focus on one absolute and immutable goal: research to cure cancer – cures for all types of cancer. Since 1973 with grass roots support of Americans NFCR has been a catalyst for the discovery of the…...
Labs Navigate the “Valley of Death”
Here is the hard truth: Research is expensive. Salaries, equipment, upgrades, experiments, clinical trials and prototyping voraciously eat up budgets, even those in the tens or hundreds of millions of dollars. And this is before success (or failure) is declared. Unfortunately, just because a cancer laboratory gets a grant from…...